Project Grant R01AI184997
Award Date
9/12/24
Completion Date
7/31/29
Dollars Obligated
$616K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The federal Project Grant award of $101,290 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to strengthen grants administration capacity at the Makerere University College of Health Sciences in Uganda. The key products and services to be delivered under this award include: Providing advanced training and mentorship to senior research administrators at Makerere University on best practices for pre- and post-award...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to investigate the molecular mechanisms regulating neutrophil proinflammatory activity in sepsis. The $479,249 award will fund a study to determine how neutrophil signaling through the A20 protein contributes to organ damage and vaso-occlusive events in sepsis. The research will employ biochemical, cell...
This $462,000 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate how the human microbiome regulates neutrophil immune responses and impacts sepsis outcomes. The key objectives are to: Elucidate the mechanism by which the microbiome "primes" or trains human neutrophils during homeostasis, leading to differential inflammatory responses....
The federal Project Grant award R01AI182253, with a total funding amount of $708,202.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The goal of this 5-year grant is to discover the targets of naturally acquired protection against severe Plasmodium falciparum malaria and develop them as novel blood-stage vaccine candidates. The research activities will be conducted by the prime awardee,...
This federal Project Grant award in the amount of $746,813.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to increase appropriate treatment of Shigella while limiting antimicrobial resistance in low-resource settings. The key objectives are to: 1) characterize the impact of inappropriately treated Shigella on diarrhea outcomes in children in Tanzania, 2) evaluate novel...
The federal Project Grant award R01AI188576, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), is focused on developing a human-centered artificial intelligence (HCAI) system to improve early prediction and decision-making for sepsis. The key products and services to be delivered under this $444,506 award include: 1) creating a deidentified database with complete electronic health record (EHR)...
This $146,170 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a global infectious disease research framework at the University of Virginia (UVA). The funding will allow the principal investigator, a mid-career researcher, to dedicate time towards mentoring junior faculty engaged in global health research and developing a university-wide cohort of global health...
This federal Project Grant award R01AI183599 in the amount of $1,553,810 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to evaluate a genomic surveillance approach for monitoring the emergence of artemisinin resistance in Plasmodium falciparum malaria parasites in Africa. The key objectives are to: 1) identify parasite genetic loci under selection over time...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $201,549 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Medical University of South Carolina (MUSC) to study metabolic syndrome outcomes among tuberculosis (TB) patients in Tanzania. The key products and services to be delivered under this grant include: Measuring and characterizing a set of blood-based and anthropometric metabolic markers, as well as TB severity, among TB...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,564,570 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on identifying drivers of genital inflammation and HIV acquisition in women living in sub-Saharan Africa. The project will run from August 2024 through June 2029. The grant supports several key products and...